CND Life Sciences
PrivateLast Round
Seed Round
Jun 16, 2026
Total Funding Raised
$34.72M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CND Life Sciences is a biotechnology company that provides a diagnostic test to aid in the confirmation of synucleinopathies like Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Medical AI, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CND Life Sciences Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
CND Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 16, 2026 | ||||
| Grant | Oct 22, 2025 | ||||
| Series A | May 1, 2025 | ||||
| Grant | Nov 20, 2024 | ||||
| Grant | May 1, 2023 | ||||
Grant | May 18, 2022 |
Key People
Founding team and executive leadership
CND Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| VILAS Ventures | Series A |
| Top Corner Capital | Series A, Grant |
| Lupo Labs | Series A |
| NIH RADx | Grant |
| National Institute on Aging | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Cambrian Growth Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 16, 2026
Raised $4.3M in Seed funding.
- Oct 22, 2025
Secured $3M in grant funding.
CND Life Sciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CND Life Sciences's valuation, stock price, and market status.